Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device

Abstract

Mechanical circulatory assist devices (MCADs) are increasingly utilized independently of cardiac transplantation in the management of heart failure. Though MCAD use incorporates inherent mechanical risks, the inevitable onset of chronic anemia, with its associated morbidity and mortality, is also a significant concern. MCAD support has been correlated with elevated plasma levels of inflammatory cytokines TNF-alpha, IL-1beta, and IL-6, which have separately been found to inhibit erythropoietin (Epo)-induced erythrocyte (RBC) maturation. Previous analysis of hematological parameters for MCAD-supported patients concluded that an amplified inflammatory response impedes RBC proliferation and recovery from hemolytic anemia. Additional analysis may bolster this assertion. Hemoglobin concentration (HC), RBC distribution width (RDW), mean cell volume (MCV), and cardiac index were retrospectively analysed for 78 MCAD-supported patients implanted for greater than 30 days at the University of Arizona Health Sciences Center from 1996 to 2002. Analysis confirms that the HC, a conventional marker for anemia, declines with MCAD placement and remains below the clinically defined, minimum normal value. Inversely, the RDW rises above maximum normal measure, signifying an increased fraction of juvenile RBCs. The MCV remains unchanged and within normal limits, demonstrating adequate substrate for RBC formation. MCAD performance also stabilizes as adequate perfusion returns. These results further support our previously published conclusion that a sufficient response of erythropoiesis occurs in reaction to the onset of anemia by an increased production of immature RBCs. However, the cells never fully mature and join circulation. The patient's inflammatory cytokine response to the implanted device most likely mediates the chronic MCAD-induced anemia by inhibition of Epo effects.

The relationship of hematoma growth to rdw in patients with hypertensive intracerebral hemorrhage

“…Inflammatory cytokines and neurohumoral mediators are activated in acute and chronic cardiovascular diseases. Inflammatory cytokines have been found to suppress the maturation of erythrocytes, and the increased immature erythrocytes may therefore reflect higher RDW levels (15). Admission RDW (aRDW) has recently been shown to predict mortality in trauma patients by an unclear mechanism (14).…”

The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study

“…Possible contribution of inflammation to anisocytosis results from inhibition of the response production against erythropoietin, impaired iron metabolism, and shortened time of red blood cell survival [19]. In addition, it has been found in previous studies that inflammatory cytokines suppress the maturation of erythrocytes, therefore immature erythrocytes which enter the circulation may accelerate erythropoiesis [20]. Previously, we published first outcomes of this study and demonstrated that there was a good correlation between hs-CRP level, which is an important inflammatory marker and RDW level on admission [21].…”

Red Blood Cell Distribution Width (RDW) and its Association with Coronary Atherosclerotic Burden in Patients with Stable Angina Pectoris

“…Another possible mechanism is the increased levels of inflammatory cytokines having impacts on iron metabolism and bone marrow function (11,12). RDW is related to the proliferative responses of erythropoiesis and will rise in similar fashion with the reticulocyte count during increased production of immature RBCs (16). In a recent study (17), Gotsman et al have shown that TNF-α and IL-6 levels are related to Gensini score.…”